The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. iData’s cardiovascular device market reports also include cardiac surgery, cardiac rhythm management, and other cardiovascular devices and procedures. Check out our different cardiovascular device market reports below.
In 2020, the U.S. Transcatheter Aortic Valve Replacement (TAVR) market size was valued at almost $2.4 billion, with over 75,000 TAVR procedures performed annually. In spite of COVID19, the market size is expected to increase at a cumulative growth rate of 8.7% to reach almost $5 billion in 2026. Throughout this medical market research, we
By 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies
By 2020, the U.S. vascular access devices market size was valued at $4.8 billion, with over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year. In spite of COVID19, the market size is expected to increase over the forecast period at a compound annual growth rate (CAGR) of 2.7% to reach $5.7
By 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive